Enlivex Therapeutics Chooses Rain as DAT Partner with High-Level Political Support

Israel-based Enlivex, developing Allocetra immunotherapy, partners with Rain for DAT initiatives, backed by a former Italian prime minister.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • DAT (Drug Administration Technology): A system or platform designed to support the administration and delivery of pharmaceutical or biotechnology treatments.
  • Macrophage reprogramming: A therapeutic approach that alters the behavior of macrophages, a type of immune cell, to improve immune response or treat disease.
  • Allocetra: An experimental immunotherapy by Enlivex designed for macrophage reprogramming to treat severe inflammatory conditions.